BG108587A - Пептиди притежаващи анти -ангиогенна активност - Google Patents

Пептиди притежаващи анти -ангиогенна активност Download PDF

Info

Publication number
BG108587A
BG108587A BG108587A BG10858704A BG108587A BG 108587 A BG108587 A BG 108587A BG 108587 A BG108587 A BG 108587A BG 10858704 A BG10858704 A BG 10858704A BG 108587 A BG108587 A BG 108587A
Authority
BG
Bulgaria
Prior art keywords
ile
arg
nva
thr
pronhch
Prior art date
Application number
BG108587A
Other languages
Bulgarian (bg)
English (en)
Inventor
Fortuna Haviv
Michael Bradley
Douglas Kalvin
Jack Henkin
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of BG108587A publication Critical patent/BG108587A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG108587A 2001-07-26 2004-02-18 Пептиди притежаващи анти -ангиогенна активност BG108587A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/915,956 US20030050246A1 (en) 2001-07-26 2001-07-26 Peptides having antiangiogenic activity

Publications (1)

Publication Number Publication Date
BG108587A true BG108587A (bg) 2005-03-31

Family

ID=25436471

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108587A BG108587A (bg) 2001-07-26 2004-02-18 Пептиди притежаващи анти -ангиогенна активност

Country Status (14)

Country Link
US (1) US20030050246A1 (fr)
EP (1) EP1421107A1 (fr)
JP (1) JP2005507864A (fr)
AR (1) AR034890A1 (fr)
BG (1) BG108587A (fr)
CA (1) CA2454753A1 (fr)
CZ (1) CZ2004283A3 (fr)
HU (1) HUP0401629A2 (fr)
MX (1) MXPA04000805A (fr)
PE (1) PE20030302A1 (fr)
PL (1) PL368745A1 (fr)
SK (1) SK1172004A3 (fr)
UY (1) UY27394A1 (fr)
WO (1) WO2003011896A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067490B2 (en) * 2001-10-31 2006-06-27 Abbott Laboratories Hepta-, Octa-and nonapeptides having antiangiogenic activity
US20030228365A1 (en) * 2002-06-07 2003-12-11 Fortuna Haviv Pharmaceutical formulation
US8906859B2 (en) 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
US8236766B2 (en) 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
MY148144A (en) 2006-11-10 2013-03-15 Cara Therapeutics Inc Synthetic peptide amides
US7713937B2 (en) 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
RU2447848C2 (ru) * 2010-07-26 2012-04-20 Государственное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Способ профилактики полостных спаек

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512591A (en) * 1993-02-18 1996-04-30 President And Fellows Of Harvard College Treatments for diseases characterized by neovascularization
AR018371A1 (es) * 1998-05-22 2001-11-14 Abbott Lab Compuestos peptidicos antiangiogenicos y composiciones farmaceuticas.

Also Published As

Publication number Publication date
PL368745A1 (en) 2005-04-04
CZ2004283A3 (cs) 2004-07-14
US20030050246A1 (en) 2003-03-13
EP1421107A1 (fr) 2004-05-26
WO2003011896A1 (fr) 2003-02-13
SK1172004A3 (en) 2004-08-03
HUP0401629A2 (hu) 2004-11-29
UY27394A1 (es) 2003-02-28
PE20030302A1 (es) 2003-03-27
MXPA04000805A (es) 2004-06-03
CA2454753A1 (fr) 2003-02-13
AR034890A1 (es) 2004-03-24
JP2005507864A (ja) 2005-03-24

Similar Documents

Publication Publication Date Title
US20020183242A1 (en) Peptide antiangiogenic drugs
EP1232183B1 (fr) Peptides presentant une activite anti-angiogenique
US20050215484A1 (en) Di-, tri-, and tetra-peptides having antiangiogenic activity
BG108587A (bg) Пептиди притежаващи анти -ангиогенна активност
EP1242455A1 (fr) Peptides n-alkylates presentant une activite antiangiogenique
US20060194737A1 (en) Hepta-, octa-and nonapeptides having antiangiogenic activity
US20030045477A1 (en) Peptides having antiangiogenic activity
US6777535B1 (en) N-alkylated peptides having antiangiogenic activity
US6753408B1 (en) Peptides having antiangiogenic activity
CA2466170C (fr) Hexa-, hepta- et octapeptides a activite anti-angiogenique
EP2177530B1 (fr) Octapeptide à l'activité anti-angiogenique
US7169888B2 (en) Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
WO2003037269A2 (fr) Di-, tri,- et tetrapeptides ayant une activite antiangiogenique
EP1451209A2 (fr) Tetra-, penta-, hexa- et heptapeptides possedant une activite anti-angiogenique
US20030119745A1 (en) HEXA- and heptapeptides having antiangiogenic activity
AU2002353929A1 (en) Hepta-, octa- and nonapeptides having antiangiogenic activity
WO2003065974A2 (fr) Hexa-, hepta-, et octapeptides a activite anti-angiogenique